Michael J. Birrer, MD of Massachusetts General Hospital discusses guidelines for micro satellite instability or MSI testing for endometrial patients at SGO 2016.
Transcription:
So we established a. Policy and mass general to stain for MSH six. And other mismatch repair proteins. In. Patients who have an image of cancer under the age of fifty. That is consistent with the NCC and guidelines. Yes Yohe guidelines actually puts the age limit at six. And my guess is with time we will be doing on on everybody. A because it has a bit of a fairly large impact. In that Frizzle prognostic Levi’s patients do better. Namely now may have. Target there before this is a mismatch repair they may respond to. Agents at target DNA repair life partner hitters. But you I think it’s incredibly rational to think about them it for as candidates for immuno therapy I would love to see a trial for that and I know for a fact at least two investigators of uri written concepts. At that are working your way through industry to propose to to conduct those kinds of trials.